Over $20 Million Paid to a Select Group of Top U.S. Oncologists
— “The findings identify a risk for perceived and real conflict of interest,” study author says
by Michael DePeau-Wilson, Enterprise & Investigative Writer, MedPage Today June 27, 2022
“These physicians hold important leadership positions, draft treatment guidelines, and are often on journal editorial boards,” Booth told MedPage Today in an email. “The findings identify a risk for perceived and real conflict of interest. Because of the leadership positions they hold, the potential impact of this small group of physicians on oncology practice and policy may be substantial.”
Since even small payments have been found to influence prescribing practices, the higher value payments to the selected group of physicians with leadership roles were “worrisome,” Booth said.
“What happens next will require some soul searching within the oncology community,” Booth said. “Oncology specialty associations, guideline panels, and journal editorial boards should re-consider if it is appropriate for physicians with such large payments to hold these high-profile positions. It is unlikely that patients and the general public would look favorably upon industry relationships that involve hundreds of thousands of dollars.”
- Michael DePeau-Wilson is a reporter on MedPage Today’s enterprise & investigative team. He covers psychiatry, long covid, and infectious diseases, among other relevant U.S. clinical news.
Read the whole article here: